1. Home
  2. NKTR vs BETR Comparison

NKTR vs BETR Comparison

Compare NKTR & BETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • BETR
  • Stock Information
  • Founded
  • NKTR 1990
  • BETR 2014
  • Country
  • NKTR United States
  • BETR United States
  • Employees
  • NKTR N/A
  • BETR N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • BETR Finance: Consumer Services
  • Sector
  • NKTR Health Care
  • BETR Finance
  • Exchange
  • NKTR Nasdaq
  • BETR Nasdaq
  • Market Cap
  • NKTR 160.4M
  • BETR 186.6M
  • IPO Year
  • NKTR 1994
  • BETR N/A
  • Fundamental
  • Price
  • NKTR $0.74
  • BETR $11.70
  • Analyst Decision
  • NKTR Strong Buy
  • BETR
  • Analyst Count
  • NKTR 5
  • BETR 0
  • Target Price
  • NKTR $5.50
  • BETR N/A
  • AVG Volume (30 Days)
  • NKTR 1.4M
  • BETR 49.9K
  • Earning Date
  • NKTR 03-12-2025
  • BETR 03-18-2025
  • Dividend Yield
  • NKTR N/A
  • BETR N/A
  • EPS Growth
  • NKTR N/A
  • BETR N/A
  • EPS
  • NKTR N/A
  • BETR N/A
  • Revenue
  • NKTR $98,427,000.00
  • BETR $108,488,000.00
  • Revenue This Year
  • NKTR N/A
  • BETR N/A
  • Revenue Next Year
  • NKTR N/A
  • BETR N/A
  • P/E Ratio
  • NKTR N/A
  • BETR N/A
  • Revenue Growth
  • NKTR 9.21
  • BETR 49.97
  • 52 Week Low
  • NKTR $0.65
  • BETR $7.71
  • 52 Week High
  • NKTR $1.93
  • BETR $30.00
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 36.32
  • BETR 50.08
  • Support Level
  • NKTR $0.84
  • BETR $9.96
  • Resistance Level
  • NKTR $0.92
  • BETR $14.43
  • Average True Range (ATR)
  • NKTR 0.08
  • BETR 1.13
  • MACD
  • NKTR -0.01
  • BETR 0.07
  • Stochastic Oscillator
  • NKTR 0.40
  • BETR 48.10

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About BETR Better Home & Finance Holding Company

Better Home & Finance Holding Co is a digital-first homeownership company whose services include mortgage, real estate, title, and homeowners insurance. The company has combined technology innovation and fresh thinking with a deep customer focus with the goal of revolutionizing the homeownership industry.

Share on Social Networks: